BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17823660)

  • 21. Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system.
    Kiang A; Hartman ZC; Everett RS; Serra D; Jiang H; Frank MM; Amalfitano A
    Mol Ther; 2006 Oct; 14(4):588-98. PubMed ID: 16733096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.
    Tosch C; Geist M; Ledoux C; Ziller-Remi C; Paul S; Erbs P; Corvaia N; Von Hoegen P; Balloul JM; Haegel H
    Cancer Gene Ther; 2009 Apr; 16(4):310-9. PubMed ID: 18949016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug evaluation: TG-1042, an adenovirus-mediated IFNgamma gene delivery for the intratumoral therapy of primary cutaneous lymphomas.
    Urosevic M
    Curr Opin Investig Drugs; 2007 Jun; 8(6):493-8. PubMed ID: 17621880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide.
    Hamada K; Sakaue M; Sarkar A; Buchl S; Satterfield W; Keeling M; Sastry J; Roth JA; Follen M
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S177-86. PubMed ID: 16214207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
    Meier V; Mihm S; Ramadori G
    J Med Virol; 2008 Nov; 80(11):1912-8. PubMed ID: 18814253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered adenovirus serotypes for overcoming anti-vector immunity.
    Dharmapuri S; Peruzzi D; Aurisicchio L
    Expert Opin Biol Ther; 2009 Oct; 9(10):1279-87. PubMed ID: 19645630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice.
    Matteoli G; Fahl E; Warnke P; Müller S; Bonin M; Autenrieth IB; Bohn E
    BMC Microbiol; 2008 Sep; 8():153. PubMed ID: 18803824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene transfer into brain parenchyma elicits antitumor effects.
    Fathallah-Shaykh HM; Kafrouni AI; Zhao LJ; Smith GM; Forman J
    Cancer Res; 2000 Apr; 60(7):1797-9. PubMed ID: 10766160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into the evolution of IFNs: zebrafish group II IFNs induce a rapid and transient expression of IFN-dependent genes and display powerful antiviral activities.
    López-Muñoz A; Roca FJ; Meseguer J; Mulero V
    J Immunol; 2009 Mar; 182(6):3440-9. PubMed ID: 19265122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications.
    Ferrantini M; Belardelli F
    Semin Cancer Biol; 2000 Apr; 10(2):145-57. PubMed ID: 10936064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and identification of a recombinant adenovirus which expresses human interferon-gamma.
    Xu R; Ying B; Zhao S; Li C; Wang Y
    Chin J Biotechnol; 1997; 13(1):1-8. PubMed ID: 9376501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterisation and expression analysis of interferon gamma in Atlantic cod (Gadus morhua).
    Furnes C; Seppola M; Robertsen B
    Fish Shellfish Immunol; 2009 Feb; 26(2):285-92. PubMed ID: 19100838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The search for the IFN-gamma receptor in fish: Functional and expression analysis of putative binding and signalling chains in rainbow trout Oncorhynchus mykiss.
    Gao Q; Nie P; Thompson KD; Adams A; Wang T; Secombes CJ; Zou J
    Dev Comp Immunol; 2009 Aug; 33(8):920-31. PubMed ID: 19454334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy.
    Van Roy M; Wielockx B; Baker A; Libert C
    Cancer Gene Ther; 2007 Apr; 14(4):372-9. PubMed ID: 17218947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demyelination but no cognitive, motor or behavioral deficits after adenovirus-mediated gene transfer into the brain.
    Fathallah-Shaykh HM; Kafrouni AI; Zhao LJ; Diaz-Arrastia R; Garcia JA; Frawley WH; Forman J
    Gene Ther; 2000 Dec; 7(24):2094-8. PubMed ID: 11223990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.
    Tomihara K; Kato K; Masuta Y; Nakamura K; Uchida H; Sasaki K; Tanaka T; Huang J; Hiratsuka H; Hamada H
    Gene Ther; 2008 Feb; 15(3):203-13. PubMed ID: 17989706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response.
    Zaiss AK; Vilaysane A; Cotter MJ; Clark SA; Meijndert HC; Colarusso P; Yates RM; Petrilli V; Tschopp J; Muruve DA
    J Immunol; 2009 Jun; 182(11):7058-68. PubMed ID: 19454703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.